Form 4: Elevance Health Executive Reports Stock Transactions

Peter D. Haytaian, an EVP at Elevance Health, reports the acquisition and disposal of company stock related to vesting restricted stock units.

Summary

• On November 1, 2024, Peter D. Haytaian, an Executive Vice President at Elevance Health, engaged in transactions involving Elevance Health's common stock.
• Haytaian disposed of 1,649 shares to cover tax liabilities associated with the vesting of previously granted restricted stock at a price of $414.01 per share.
• He also acquired 3,799 performance-based restricted share units that vested on the same date.
• Following these transactions, Haytaian directly owns 21,037 shares of Elevance Health common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
• The filing provides transparency to shareholders regarding insider transactions.

Key Dates